Trial intelligence / Profile preview

Prophylactic ondansetron versus ephedrine for prevention of spinal anesthesia-associated hypotension in cesarean section

IRCT20141009019470N106Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of ondansetron and ephedrine in hypotension (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Hemodynamic changes, Nausea and vomiting and 1 more. Started Feb 2021; status: completed.

02

Drugs

ondansetronephedrine
03

Conditions

hypotension

Beyond the preview

Go deeper on IRCT20141009019470N106.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141009019470N106.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call